<DOC>
	<DOCNO>NCT01664013</DOCNO>
	<brief_summary>The purpose study investigate impact botulinum toxin treatment quality life ( QoL ) cervical dystonia patient</brief_summary>
	<brief_title>The Impact Botulinum Toxin Treatment Quality Life Cervical Dystonia Patients</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>age â‰¥ 18 year 75 year Subjects require treatment clinical diagnosis cervical dystonia Willing provide write informed consent studyrelated procedure . Patients pure anterocollis Patients anaphlyactic response history botulinum toxin type A . Patients treat botulinum toxin type A within 3 month . Females pregnant , planning pregnancy , unable use contraception lactate . Any medical condition may put subject increase risk exposure botulinum toxin discrimination investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>